6OP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 2.994 EUR 2.32%

Market Cap: €65.2m

	OSE Immunotherapeutics SA F:6OP	FR
	CBAK Energy Technology Inc NASDAQ:CBAT	CN
	Rusolovo PAO MOEX:ROLO	RU
S	Sartorius Stedim Biotech SA OTC:SRTOY	FR
L	Labat Africa Ltd JSE:LAB	ZA
	I-nexus Global PLC LSE:INX	UK
E	EDP Energias de Portugal SA ELI:EDP	PT
I	IBI-Lion SOCIMI SA MAD:YIBI	ES
	Tiong Seng Holdings Ltd SGX:BFI	SG

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 389%

Negative 3Y Average Operating Margin

-783%

Declining Operating Margin

-811% > -1 389%

Negative Net Margin

-1 396%

Negative 3Y Average Net Margin

-780%

Declining Net Margin

-769% > -1 396%

Negative Free Cash Flow Margin

-1 380%

Negative 3Y Average Free Cash Flow Margin

-766%

Declining Free Cash Flow Margin

-784% > -1 380%

Negative ROE

-66%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

Declining ROIC

-51% > -68%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.